UCHealth Eye Center - LoDo
1435 Wazee St, Suite 101 Denver, CO 80202Phone: 720-553-0393
Prem Subramanian, MD, PhD
Ophthalmology
Board Certified
Care Philosophy
I serve patients with complex medical and neurological problems that often go beyond the eye, and my approach is to make as specific a diagnosis as possible with the goal of improving visual function and overall health through medical and surgical treatments.
Clinical Interest for Patients
I provide medical and surgical care for patients with many neuro-ophthalmic conditions including thyroid eye disease, pseudotumor cerebri, optic nerve problems, double vision, orbital tumors, and brain tumors causing visual problems.
Title(s)
Chair, Faculty Promotions Committee, Chief, Neuro-Ophthalmology
Credentials
Doctor of Philosphy Doctor of Medicine
Specialty
Ophthalmology
Scheduling Phone Number
720-848-2020
Gender
Male
Languages
English, Tamil, German
Hospital Affiliation
Children's Hospital Colorado, University of Colorado Hospital
UCHealth Sue Anschutz-Rodgers Eye Center
Phone: 720-848-2020 720-848-2020
Provider Information
Specialties
- Ophthalmology (2002,2022)
Conditions
-
Eyes and Vision
Eye Disease , Lazy Eye , Double Vision , Neuro-Ophthalmology , Pediatric Ophthalmology and Adult Strabismus , Optic Nerve Swelling , Thyroid Eye Disease , Ophthalmic Oncology
-
Brain and Nervous System
Myasthenia gravis , Optic Neuritis , Pituitary Disorders , Optic Nerve Disorders , Chiari Malformation , Visual Field Loss , Visual Disturbances , Vision Loss , Pseudotumor Cerebri , Myelin Oligodendrocyte Antibody Disease (MOGAD) , Brain Tumors , Nystagmus , Pupil Abnormalities , Neuromyelitis optica (NMO) , SUSAC Syndrome , Visual Hallucinations
-
Surgery
Neurosurgery , Eye and/or Orbital
-
Endocrine System (Hormones)
Thyroid Disease
-
Cancers
Brain Cancer , Eye , Cancer Surgery
-
Ear, Nose, and Throat (ENT)
Skull Base Tumors
Treatments and Services
- Eyes and Vision
- Brain and Nervous System
Interests and Activities
Personal Interests
I play French horn with the Colorado Wind Ensemble, and I am also an active cyclist and downhill skier.
Volunteer Activities
I am on the Board of Directors of Opera Colorado and am an avid supporter of the arts in Denver and beyond.
Department
Professor, Ophthalmology
Professional Memberships
American Academy of Ophthalmology (AAO), Fellow American Association for Pediatric Ophthalmology and Strabismus (AAPOS), Associate Member American Medical Association (AMA), Member American Society for Ocular Trauma (ASOT), Member Association for Research and Vision in Ophthalmology (ARVO), Member International Society for Ocular Trauma (ISOT), Member North American Neuro-Ophthalmology Society (NANOS), Board member North American Society of Academic Orbital Surgeons, Charter Member Pan-American Association for Ophthalmology (PAAO), Member Sigma Xi, Member
Research and Grants
Grants
Idiopathic Intracranial Hypertension Treatment Trial (2011)
Open Label Study of Celecoxib in Treating Mild Thyroid Eye Disease (2014)
Education and Training
Medical Schools
MD, Baylor College of Medicine (1997)
Undergraduate Schools
AB, Princeton University (NJ) (1989)
Graduate Schools
PhD, Baylor College Of Medicine (1995)
Internships
National Capital Consortium (Walter Reed) Program (1998)
Residency Program
National Capital Consortium (Walter Reed) Program (2001)
Fellowships
Johns Hopkins University School of Medicine Program (2003)
Information for referring providers
Referral Contact Phone
720-848-2020
Referral Contact Fax
720-848-5079
Referring Patients Link
Clinical Interests for Referring Providers
My interests include thyroid eye disease (medical and surgical management), pseudotumor cerebri, orbital tumors, adult strabismus/surgery, optic neuropathy, and skull base tumor surgery.
Research Interest for Referring Providers
My primary research interest involves the characterization of visual dysfunction induced by efferent (ocular motor) disorders at both the supranuclear and infranuclear levels. Our efforts are directed at identifying predictors of spontaneous recovery as well as persistent deficits in order to target those patients who would benefit most from early intervention.